Net Income (Loss) Attributable to Parent in USD of Surface Oncology, Inc. from 2016 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Surface Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2016 to Q2 2023.
  • Surface Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Jun 2023 was -$28.2M, a 11.8% decline year-over-year.
  • Surface Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Jun 2023 was -$92.5M, a 46.9% decline year-over-year.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63.6M, a 19% increase from 2021.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$78.5M, a 232% decline from 2020.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was $59.3M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Surface Oncology, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$92.5M -$28.2M -$2.98M -11.8% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2023
Q1 2023 -$89.5M -$19.7M -$25.9M -418% 01 Jan 2023 31 Mar 2023 10-Q 02 Aug 2023
Q4 2022 -$63.6M -$21.3M +$2.72M +11.3% 01 Oct 2022 31 Dec 2022 8-K 03 Jul 2023
Q3 2022 -$66.3M -$23.2M -$3.35M -16.8% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 -$63M -$25.2M -$6.23M -32.8% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 -$56.7M $6.2M +$21.8M 01 Jan 2022 31 Mar 2022 10-Q 02 Aug 2023
Q4 2021 -$78.5M -$24.1M -$91.4M -136% 01 Oct 2021 31 Dec 2021 8-K 03 Jul 2023
Q3 2021 $12.9M -$19.9M -$4.12M -26.1% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $17M -$19M -$4.17M -28.2% 01 Apr 2021 30 Jun 2021 10-Q 02 Nov 2022
Q1 2021 $21.2M -$15.6M -$38.1M -169% 01 Jan 2021 31 Mar 2021 10-Q 02 Nov 2022
Q4 2020 $59.3M $67.3M +$83.3M 01 Oct 2020 31 Dec 2020 10-K 09 Mar 2021
Q3 2020 -$24M -$15.8M +$1.1M +6.54% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$25.1M -$14.8M +$2.95M +16.6% 01 Apr 2020 30 Jun 2020 10-Q 04 Nov 2021
Q1 2020 -$28M $22.6M +$26.8M 01 Jan 2020 31 Mar 2020 10-Q 04 Nov 2021
Q4 2019 -$54.8M -$16M -$11.2M -237% 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 -$43.6M -$16.9M +$344K +2% 01 Jul 2019 30 Sep 2019 10-K 09 Mar 2021
Q2 2019 -$43.9M -$17.8M -$1.91M -12% 01 Apr 2019 30 Jun 2019 10-K 09 Mar 2021
Q1 2019 -$42M -$4.2M -$35.4M -113% 01 Jan 2019 31 Mar 2019 10-K 09 Mar 2021
Q4 2018 -$6.6M -$4.74M +$11M +70% 01 Oct 2018 31 Dec 2018 10-K 10 Mar 2020
Q3 2018 -$17.6M -$17.2M -$2.82M -19.6% 01 Jul 2018 30 Sep 2018 10-K 10 Mar 2020
Q2 2018 -$14.8M -$15.9M -$9.28M -141% 01 Apr 2018 30 Jun 2018 10-K 10 Mar 2020
Q1 2018 -$5.54M $31.2M +$39.8M 01 Jan 2018 31 Mar 2018 10-K 10 Mar 2020
Q4 2017 -$45.4M -$15.8M 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019
Q3 2017 -$14.4M 01 Jul 2017 30 Sep 2017 10-K 07 Mar 2019
Q2 2017 -$6.57M 01 Apr 2017 30 Jun 2017 10-K 07 Mar 2019
Q1 2017 -$8.63M 01 Jan 2017 31 Mar 2017 10-K 07 Mar 2019

Surface Oncology, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$63.6M +$14.9M +19% 01 Jan 2022 31 Dec 2022 8-K 03 Jul 2023
2021 -$78.5M -$138M -232% 01 Jan 2021 31 Dec 2021 8-K 03 Jul 2023
2020 $59.3M +$114M 01 Jan 2020 31 Dec 2020 8-K 03 Jul 2023
2019 -$54.8M -$48.2M -731% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022
2018 -$6.6M +$38.8M +85.5% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021
2017 -$45.4M -$27.9M -160% 01 Jan 2017 31 Dec 2017 10-K 10 Mar 2020
2016 -$17.5M 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.